Aa-Risedronate Dr 35 mg

AA-Risedronate DR 35 mg is a delayed-release tablet containing risedronate sodium, used to support bone health. This medication is commonly prescribed for conditions related to bone density.

AA-Risedronate DR 35 mg is primarily used to help maintain bone density and strength. It is often prescribed for conditions such as osteoporosis, where the primary goal is to support bone health and reduce the risk of fractures. Risedronate sodium works by slowing down the process of bone breakdown, helping to preserve bone structure.

Common effects of AA-Risedronate DR 35 mg may include gastrointestinal discomfort, such as nausea or stomach pain. Some users might experience heartburn or difficulty swallowing. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

AA-Risedronate DR 35 mg should be taken with a full glass of water, and the tablet should not be crushed or chewed. It is important to stay upright for at least 30 minutes after taking the medication to help it reach the stomach properly. This medication should be taken on an empty stomach, preferably in the morning.

AA-Risedronate DR 35 mg may interact with certain medications, including antacids and other oral supplements. It is advisable to avoid taking other medications within two hours of taking risedronate sodium. Additionally, alcohol consumption should be limited, as it can affect the absorption and effectiveness of the medication.